PubMed:32471876 / 38-44
Registries Offer Insights on COVID-19-Cancer Connection.
Findings from CCC19 and TERAVOLT suggest that patients with cancer may be more likely to die from COVID-19 than people in the general population. Additional mortality risk factors may include age, performance status, treatment with chemotherapy, and exposure to hydroxychloroquine plus azithromycin.
|
projects
Unselected / annnotation | Selected / annnotation | |
|
|
|